Figures & data
Figure 1 Summary of current and investigational anti-integrin therapies and their targets in inflammatory bowel disease. Created with BioRender.com.
Clinical and Experimental Gastroenterology
Volume 14, 2021 - Issue
Review
Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives
John Gubatan1 Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USACorrespondence[email protected]
https://orcid.org/0000-0001-6037-2883View further author information
https://orcid.org/0000-0001-6037-2883View further author information, , Samuel J S Rubin2 Stanford University School of Medicine, Stanford, CA, USA;3 Immunology Program, Stanford University School of Medicine, Stanford, CA, USAhttps://orcid.org/0000-0001-7335-3868View further author information
https://orcid.org/0000-0001-7335-3868View further author information, , Cyrus A Buckman2 Stanford University School of Medicine, Stanford, CA, USAhttps://orcid.org/0000-0003-1360-8691View further author information
https://orcid.org/0000-0003-1360-8691View further author information &